| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 1,767.0 | 800.0 |
| Profit before tax | 74.0 | 170.0 |
| Net income | 81.0 | 149.0 |
| EPS (diluted, $ a share) | $0.82 | $2.50 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Net income, year on year | -45.6% |
|---|---|
| Revenue, year on year | +120.9% |
| Operating margin | 7.2% |
10-Q filed with the SEC, NYSE: WAT. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Waters Corp: key numbers
- Share price
- $453.42Close, Nov 16
- Market cap
- $44.6B
- Shares outstanding
- 98.29MLatest SEC cover page
- Sector
- Industrial Applications and Services
- Industry
- Laboratory Analytical InstrumentsSIC 3826
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Waters Corp
All →Waters Financial Results
Waters Corporation reported Q3 2026 revenue of $1.767 billion, exceeding guidance midpoints with 9% organic revenue growth. The company raised its full-year 2026 guidance by $43 million at the midpoint, citing strong execution in consumables and double-digit growth in LC-MS instruments.
- Term
- Q3 2026
“Our team delivered exceptional results led by best-in-class consumables growth across both our Analytical Sciences and Biosciences divisions, as strong execution, new product innovation, and rising customer testing volume accelerated growth.”
Dr. Udit Batra, President & Chief Executive Officer
“Thanks to the hard work of our teams, we are delivering ahead of schedule on our synergy and integration commitments for our acquired businesses. With improving end market conditions and momentum accelerating across the combined company, we are raising our full year 2026 revenue guidance by $43 million at the midpoint and our fourth quarter guidance calls for double digit growth in both our organic and acquired businesses on a days adjusted basis.”
Dr. Udit Batra, President & Chief Executive Officer